Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging.
作者信息
Pysz Marybeth A, Willmann Jürgen K
机构信息
Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, California 94305, USA.
出版信息
Gastroenterology. 2011 Mar;140(3):785-90. doi: 10.1053/j.gastro.2011.01.027. Epub 2011 Jan 18.
Abstract
摘要
相似文献
1
Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging.
Gastroenterology. 2011 Mar;140(3):785-90. doi: 10.1053/j.gastro.2011.01.027. Epub 2011 Jan 18.
2
Ultrasound contrast materials in cardiovascular medicine: from perfusion assessment to molecular imaging.
J Cardiovasc Transl Res. 2013 Oct;6(5):729-39. doi: 10.1007/s12265-013-9501-0. Epub 2013 Aug 3.
3
Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications for angiogenesis.
J Cardiovasc Transl Res. 2011 Aug;4(4):404-15. doi: 10.1007/s12265-011-9282-2. Epub 2011 May 3.
4
Molecular imaging of myocardial and vascular disorders with ultrasound.
JACC Cardiovasc Imaging. 2010 Feb;3(2):204-11. doi: 10.1016/j.jcmg.2009.09.021.
5
Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application.
AJR Am J Roentgenol. 2012 Aug;199(2):292-9. doi: 10.2214/AJR.12.8826.
6
Assessing the clinical utility of color Doppler ultrasound for ovarian torsion in the setting of a negative contrast-enhanced CT scan of the abdomen and pelvis.
Abdom Imaging. 2015 Oct;40(8):3206-13. doi: 10.1007/s00261-015-0535-4.
7
When is contrast needed for abdominal and pelvic CT?
Cleve Clin J Med. 2020 Oct 1;87(10):595-598. doi: 10.3949/ccjm.87a.19093.
8
Molecular ultrasound imaging: current status and future directions.
Clin Radiol. 2010 Jul;65(7):567-81. doi: 10.1016/j.crad.2010.02.013.
9
Contrast-Enhanced Ultrasound Guidance for Interventional Procedures.
J Ultrasound Med. 2019 Oct;38(10):2541-2557. doi: 10.1002/jum.14955. Epub 2019 Feb 4.
10
Update on abdominal imaging: contrast enhanced ultrasonography.
JBR-BTR. 2007 Nov-Dec;90(6):497-502.
引用本文的文献
1
Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.
Cancers (Basel). 2022 Jun 11;14(12):2885. doi: 10.3390/cancers14122885.
2
Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood-Brain Barrier Opening via Lipid-PLGA Nanobubbles.
Int J Nanomedicine. 2021 Nov 4;16:7433-7447. doi: 10.2147/IJN.S327737. eCollection 2021.
3
Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer.
Bioeng Transl Med. 2020 Sep 7;6(1):e10183. doi: 10.1002/btm2.10183. eCollection 2021 Jan.
4
Listening for the therapeutic window: Advances in drug delivery utilizing photoacoustic imaging.
Adv Drug Deliv Rev. 2019 Apr;144:78-89. doi: 10.1016/j.addr.2019.07.003. Epub 2019 Jul 8.
5
Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer.
Pancreas. 2018 Jul;47(6):675-689. doi: 10.1097/MPA.0000000000001075.
6
Towards clinically translatable nanodiagnostics.
Nat Rev Mater. 2017 May;2(5). doi: 10.1038/natrevmats.2017.14. Epub 2017 May 3.
7
Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles.
Contrast Media Mol Imaging. 2018 Mar 8;2018:8710862. doi: 10.1155/2018/8710862. eCollection 2018.
8
Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma.
Clin Cancer Res. 2018 Apr 1;24(7):1574-1585. doi: 10.1158/1078-0432.CCR-17-2057. Epub 2018 Jan 4.
9
Anatomical Road Mapping Using CT and MR Enterography for Ultrasound Molecular Imaging of Small Bowel Inflammation in Swine.
Eur Radiol. 2018 May;28(5):2068-2076. doi: 10.1007/s00330-017-5148-6. Epub 2017 Nov 23.
10
Ultrasound-guided drug delivery in cancer.
Ultrasonography. 2017 Jul;36(3):171-184. doi: 10.14366/usg.17021. Epub 2017 May 1.
本文引用的文献
1
Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
Radiology. 2011 Mar;258(3):804-11. doi: 10.1148/radiol.10101079.
2
Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging.
Invest Radiol. 2011 Mar;46(3):187-95. doi: 10.1097/RLI.0b013e3181f9202d.
3
Microbubble-enhanced US in body imaging: what role?
Radiology. 2010 Oct;257(1):24-39. doi: 10.1148/radiol.10091210.
4
Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
Invest Radiol. 2010 Oct;45(10):573-8. doi: 10.1097/RLI.0b013e3181ee8b83.
5
Science to practice: the dawn of molecular US imaging for clinical cancer imaging.
Radiology. 2010 Aug;256(2):331-3. doi: 10.1148/radiol.100717.
6
Biomarker and drug discovery for gastroenterology through translational bioinformatics.
Gastroenterology. 2010 Sep;139(3):735-41, 741.e1. doi: 10.1053/j.gastro.2010.07.024. Epub 2010 Jul 19.
7
Molecular ultrasound assessment of tumor angiogenesis.
Angiogenesis. 2010 Jun;13(2):175-88. doi: 10.1007/s10456-010-9175-z. Epub 2010 Jun 12.
8
Molecular ultrasound imaging: current status and future directions.
Clin Radiol. 2010 Jul;65(7):567-81. doi: 10.1016/j.crad.2010.02.013.
9
Molecular imaging: current status and emerging strategies.
Clin Radiol. 2010 Jul;65(7):500-16. doi: 10.1016/j.crad.2010.03.011.
10
Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).
Radiology. 2010 Aug;256(2):519-27. doi: 10.1148/radiol.10091858. Epub 2010 Jun 1.
Zotero 插件